ANVS

Annovis Bio Inc

NYSE: ANVS · HEALTHCARE · BIOTECHNOLOGY

$2.28

-5.03% today

Updated 2026-06-05

Market cap

$78.70M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.71

Dividend yield

—

52W range

$2 – $6

Volume

1.3M

Market cap

$78.70M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.71

Dividend yield

—

52W range

$2 – $6

Volume

1.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

4.5

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$12.50

+448.25%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-9.01M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-25.15M	$-56.20M	$-24.59M	$-28.85M	$-17.61M
EPS	—	—	—	—	$-1.71
Free cash flow	$-17.31M	$-39.97M	$-21.89B	$-25.62B	$-9.01M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ANVS	$78.70M	17	4.3	3.0	5.0	4.5	—	Avoid
LLY	$948.95B	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$536.54B	59	4.7	9.0	3.3	6.0	-71.41%	Buy
ABBV	$380.57B	63	4.0	8.0	4.0	5.0	-55.64%	Buy
UNH	$343.21B	54	5.3	5.5	4.7	5.5	-26.61%	Buy
MRK	$285.64B	50	3.3	8.0	2.7	5.0	-49.34%	Hold

Smart narrative

Annovis Bio Inc trades at $2.28. Our Smart Value Score of 17/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score.

Frequently asked questions

What is Annovis Bio Inc's stock price?

Annovis Bio Inc (ANVS) trades at $2.28.

Is Annovis Bio Inc overvalued?

Annovis Bio Inc carries a Smart Value Score of 17/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Annovis Bio Inc (ANVS)?

The 12-month analyst consensus target is $12.50, about 448.2% above the current $2.28. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNYSE

CurrencyUSD

www.annovisbio.com

Quick metrics

P/S ratio—

ROE-220.60%

Beta1.26

50D MA$2.04

200D MA$2.61

Shares out0.04B

Float0.03B

Short ratio—

Avg volume1.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ANVS vs LLY →ANVS vs JNJ →ANVS vs ABBV →Stock screener →